Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vireo Growth ( (TSE:VREO) ) has issued an update.
On October 2, 2025, Vireo Growth Inc. announced its entry into agreements to acquire approximately 86% of the outstanding senior secured convertible notes of Medicine Man Technologies Inc., operating as Schwazze. The acquisition, valued at around $62 million, is expected to close by the end of October 2025, pending customary approvals. This move is part of Vireo’s M&A strategy and reflects its commitment to expanding its influence in the cannabis industry. The transaction is significant as Schwazze is currently in default on its payment obligations under the notes, which are secured by various assets.
The most recent analyst rating on (TSE:VREO) stock is a Hold with a C$0.55 price target. To see the full list of analyst forecasts on Vireo Growth stock, see the TSE:VREO Stock Forecast page.
More about Vireo Growth
Vireo Growth Inc. is a pioneering medical cannabis company founded in 2014. The company focuses on building a disciplined, strategically aligned, and execution-focused platform within the cannabis industry. Vireo emphasizes a strong local market focus while leveraging a national portfolio, and is committed to hiring industry leaders and deploying capital and talent to drive value.
Average Trading Volume: 72,350
Technical Sentiment Signal: Buy
Current Market Cap: C$902.3M
Find detailed analytics on VREO stock on TipRanks’ Stock Analysis page.